Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

8.25
Delayed Data
As of 3:59pm ET
 -0.19 / -2.25%
Today’s Change
6.68
Today|||52-Week Range
36.38
-50.12%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close8.44
Today’s open8.41
Day’s range8.15 - 8.73
Volume269,601
Average volume (3 months)284,631
Market cap$209.5M
Dividend yield--
Data as of 3:59pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)-25.40%
Earnings growth (this year)+4.29%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+68.18%
P/E ratio--
Price/Sales34.95
Price/Book1.58

Competitors

 Today’s
change
Today’s
% change
CBMGCellular Biomedicine...-0.09-0.64%
OVASOvaScience Inc-0.46-7.43%
PFNXPfenex Inc-0.58-6.95%
PTGXProtagonist Therapeu...-0.54-4.70%
Data as of 4:02pm ET, 08/24/2016

Financials

Next reporting dateAugust 25, 2016
EPS forecast (this quarter)-$0.86
Annual revenue (last year)$10.5M
Annual profit (last year)-$79.3M
Net profit margin-758.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
Don Soland
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts

Partner Offers

Search for Jobs